Press release
Rising Arthritis Prevalence Fuels Expansion Of Generic Musculoskeletal Disorders Drugs Market: Powering Innovation and Expansion in the Generic Musculoskeletal Disorders Drugs Market by 2025
Generic Musculoskeletal Disorders Drugs Market
What Is the Expected CAGR for the Generic Musculoskeletal Disorders Drugs Market Through 2025?
The market size for generic drugs treating musculoskeletal disorders has seen significant growth in the past few years. The market projections show an increase from $0.06 billion in 2024 to $0.06 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.7%. This historic growth pattern is linked to factors such as the prevalence of musculoskeletal disorders, regulatory frameworks, advancements in healthcare infrastructure, enhanced patient understanding and education, as well as economic factors.
What's the Projected Size of the Global Generic Musculoskeletal Disorders Drugs Market by 2029?
Expectations are high for substantial growth in the generic musculoskeletal disorders drugs market in the coming years. Projections suggest an expansion to "$0.08 billion in 2029, at a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this predicted growth during the forecast period include increased population and aging, burgeoning markets, the rise of precision medicine and personalized treatments, healthcare reforms, and global health trends. Trends to watch in the forecast period encompass technological interventions in treatment, government schemes, and healthcare policies, a heightened focus on alternative pain management solutions, the widespread use of biosimilars, and progress in generic drug advancement.
View the full report here:
https://www.thebusinessresearchcompany.com/report/generic-musculoskeletal-disorders-drugs-global-market-report
Top Growth Drivers in the Generic Musculoskeletal Disorders Drugs Industry: What's Accelerating the Market?
The expanding incidence of arthritis is projected to drive the development of the generic musculoskeletal disorders drugs market. Arthritis, characterized by joint swelling and tenderness accompanied by symptoms of joint pain and stiffness, benefits greatly from these generic drugs, which help alleviate muscle pain and stiffness and can deal with muscle spasms in arthritis sufferers. For example, data published by Versus Arthritis, a charitable organization from the UK, in March 2022 reveals that in the UK, nearly 10 million individuals have been diagnosed with osteoarthritis, amongst which 5.4 million people have knee OA, and 3.2 million people have hip OA. In addition, around 450,000 people suffer from rheumatoid arthritis, and 190,000 people suffer from psoriatic arthritis. This adds up to more than 20 million individuals grappling with musculoskeletal ailments, leading to over 30 million prescriptions for these treatments being dispensed at a cost of about £139 million in 2022-2023. This high incidence of arthritis is thus driving the growth of the generic musculoskeletal disorders drugs market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9433&type=smp
What Trends Will Shape the Generic Musculoskeletal Disorders Drugs Market Through 2029 and Beyond?
The growing trend of strategic alliances is becoming increasingly noticeable in the generic musculoskeletal disorders drugs market. Many firms within this market segment are entering into collaborations to bolster their stronghold. For instance, the Japan-based Mitsubishi Tanabe Pharma Corporation forged an alliance with Eli Lilly and Company, a US-based pharma firm, in July 2022. This strategic partnership seeks to enhance their respective product offerings and provide effective treatment options for conditions including diabetes. Also, in February 2022, Pfizer Inc., a pharmaceutical and biotech firm based in the US, entered a business partnership with Sweden's Alex Therapeutics, a digital therapeutics company. This collaborative arrangement is expected to provide patients with clinically-proven and personalized digital therapeutics rooted in evidence-based research.
What Are the Main Segments in the Generic Musculoskeletal Disorders Drugs Market?
The generic musculoskeletal disorders drugs market covered in this report is segmented -
1) By Treatment Type: Medication, Therapy, Surgery, Other Treatment Types
2) By Disorder Type: Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types
3) By Route Of Administration: Oral, Parenteral, Other Routes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy
Subsegments:
1) By Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologics
2) By Therapy: Physical Therapy, Occupational Therapy, Chiropractic Treatment, Massage Therapy
3) By Surgery: Joint Replacement Surgery, Arthroscopy, Spinal Surgery, Fusion Surgery
4) By Other Treatment Types: Lifestyle Modifications, Alternative Therapies, Assistive Devices
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9433&type=smp
Which Top Companies are Driving Growth in the Generic Musculoskeletal Disorders Drugs Market?
Major companies operating in the generic musculoskeletal disorders drugs market include Pfizer Inc., Sanofi S.A., Eli Lilly and Company, Ampio Pharmaceuticals Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca plc, Mitsubishi Tanabe Pharma Corporation, Horizon Therapeutics plc, Eisai Co. Ltd., Biogen Inc., Sino Biopharmaceutical Limited, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Bayer AG, Mylan Pharmaceuticals Inc., Taisho Pharmaceutical Holdings Co. Ltd., Flexion Therapeutics Inc.
Which Regions Will Dominate the Generic Musculoskeletal Disorders Drugs Market Through 2029?
Asia-Pacific was the largest region in the generic musculoskeletal disorders drugs market in 2024. The regions covered in the generic musculoskeletal disorders drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9433
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Arthritis Prevalence Fuels Expansion Of Generic Musculoskeletal Disorders Drugs Market: Powering Innovation and Expansion in the Generic Musculoskeletal Disorders Drugs Market by 2025 here
News-ID: 4180397 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
